English中文

Offstream
news



Changes

  1. The Therapeutic Goods Administration grants provisional approval to the Moderna COVID-19 vaccine for children aged 12 to 17 years old.
  2. The Therapeutic Goods Administration grants provisional approval for the Moderna COVID-19 vaccine for use in children between the ages of 12 and 17.

Related